The present invention relates to compounds according to formula (I) asautotaxin inhibitors and the use of suchcompounds for the treatment and/or prophylaxis of physiological and/orpathophysiological conditions, which are caused,mediated and/or propagated by increased lysophosphatic acid levels and/or theactivation of autotaxin, in particular of different cancers.
